These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19075038)

  • 1. Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.
    Samuelson E; Hedberg C; Nilsson S; Behboudi A
    Endocr Relat Cancer; 2009 Mar; 16(1):99-111. PubMed ID: 19075038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
    Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
    Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of Endometrial Carcinoma.
    Lax SF
    Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
    Lax SF
    Virchows Arch; 2004 Mar; 444(3):213-23. PubMed ID: 14747944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.
    Konopka B; Janiec-Jankowska A; Czapczak D; Paszko Z; Bidziński M; Olszewski W; Goluda C
    J Cancer Res Clin Oncol; 2007 Jun; 133(6):361-71. PubMed ID: 17219201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches for classifying endometrial carcinoma.
    Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
    Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma.
    Yoo SH; Park BH; Choi J; Yoo J; Lee SW; Kim YM; Kim KR
    Mod Pathol; 2012 Nov; 25(11):1496-507. PubMed ID: 22766790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of endometrial carcinoma.
    Matias-Guiu X; Prat J
    Histopathology; 2013 Jan; 62(1):111-23. PubMed ID: 23240673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
    Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
    Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
    Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma.
    Boulanger E; Marchio A; Hong SS; Pineau P
    Haematologica; 2009 Aug; 94(8):1170-4. PubMed ID: 19608668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent chromosome 10 aberrations and Tp53 mutations in rat endometrial adenocarcinomas.
    Nordlander C; Samuelson E; Klinga-Levan K; Behboudi A
    Adv Exp Med Biol; 2008; 617():519-25. PubMed ID: 18497077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
    Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three cases of rare salivary gland tumours: a molecular study of TP53, CDKN2A/ARF, RAS, BRAF, PTEN, MAPK2 and EGFR genes.
    Falbo V; Floridia G; Censi F; Marra M; Foschini MP; Taruscio D
    Oncol Rep; 2011 Jul; 26(1):3-11. PubMed ID: 21503581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.